Banner Image

Test Directory

Hu, Yo, and Ri Antibodies with Reflex to Titers and Western Blot, CSF

Test Summary

Hu anti-neuronal nuclear antibody (anti-Hu) is found in 5-10% of patients with small cell carcinoma of the lung. Purkinje cell (Yo) antibody is found in patients with paraneoplastic cerebellar degeneration and is associated with breast, ovarian, and other gynecologic cancers. Some patients with ovarian cancer have low titers of Yo antibodies in the absence of cerebellar degeneration. Anti-Hu antibodies are associated with paraneoplastic encephalomyelitis and sensory neuropathy. Anti-Ri antibody can be detected in patients with paraneoplastic opsoclonus/myoclonus syndrome. Neoplasms most often associated with anti-Ri include breast cancer, small cell lung cancer, and gynecological cancers.

Aliases

  • N/A

Specimen Collection

Special Instructions

N/A

Preferred Specimen

2.4 mL CSF

Minimum Volume

1.5 mL

Instructions

N/A

Patient Preparation

Overnight fasting is preferred

Storage

Sterile screw-cap vial

Transport Temperature

Refrigerated (cold packs)

Specimen Stability

  • Room temperature: 8 hours
  • Refrigerated: 7 days
  • Frozen: 6 months

Limitations

N/A

Other Acceptable Specimens

N/A

Unacceptable Specimens

Received room temperature

Order Code

HUYORI

EPIC (Premier) Code

LAB5510

Includes

Hu Antibody Screen with Reflex to Titer and Western Blot, CSF
Yo Antibody Screen with Reflex to Titer and Western Blot, CSF
Ri Antibody Screen with Reflex to Titer and Western Blot, CSF

If Hu Antibody Screen, IFA, CSF is Positive, then Hu Antibody, WB, CSF will be performed at an additional charge (CPT code(s): 84181).
If Hu Antibody, WB, CSF is Positive, then Hu Antibody Titer, CSF will be performed at an additional charge (CPT code(s): 86256).

If Yo Antibody Screen, IFA, CSF is Positive, then Yo Antibody, WB, CSF will be performed at an additional charge (CPT code(s): 84181).
If Yo Antibody, WB, CSF is Positive, then Yo Antibody, Titer, CSF will be performed at an additional charge (CPT code(s): 86256).

If Ri Antibody Screen, IFA, CSF is Positive, then Ri Antibody, WB, CSF will be performed at an additional charge (CPT codes: 84181).
If Ri Antibody, WB, CSF is Positive, then Ri Antibody, Titer, CSF will be performed at an additional charge (CPT code(s): 86256).

CPT Code

  • 86255 (x3)

Billing Code

  • 670074

CPT Statement

Methodology

Immunofluorescence Assay (IFA)

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
33608 Ortega Highway
San Juan Capistrano CA, 92675

Department

Reference Testing

Reference Range

N/A

Setup Schedule / Expected Turnaround Time

Monday, Wednesday, Friday morning; Report available: 4 days

Specimen Collection

Special Instructions

N/A

Preferred Specimen

2.4 mL CSF

Minimum Volume

1.5 mL

Instructions

N/A

Patient Preparation

Overnight fasting is preferred

Storage

Sterile screw-cap vial

Transport Temperature

Refrigerated (cold packs)

Specimen Stability

  • Room temperature: 8 hours
  • Refrigerated: 7 days
  • Frozen: 6 months

Limitations

N/A

Other Acceptable Specimens

N/A

Unacceptable Specimens

Received room temperature

Billing

CPT Code

  • 86255 (x3)

Billing Code

  • 670074

CPT Statement

Result Information

Methodology

Immunofluorescence Assay (IFA)

Testing Laboratory

N/A

Reference Range

N/A

Setup Schedule / Expected Turnaround Time

Monday, Wednesday, Friday morning; Report available: 4 days